Noah Wyle’s commanding lead in the Outstanding Lead Actor in a Drama Series market reflects The Pitt’s dominant 25-nomination haul and his status as defending champion, bolstered by strong critical reception for his layered portrayal of Dr. Robby in season two. Industry predictors and guild momentum have consolidated trader consensus around the HBO Max medical drama’s repeat frontrunner narrative, with Wyle’s episode submissions highlighting emotional depth that resonates with academy voters. The ceremony arrives September 14, leaving little room for late shifts, though a surge from established contenders like Gary Oldman or Sterling K. Brown could theoretically disrupt the outcome if voter fatigue or unexpected campaign dynamics emerge in final ballots.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourEmmys 2026 : Meilleur acteur principal dans une série dramatique
Noah Wyle – « The Pitt » 94%
Sterling K. Brown – « Paradise » 3.1%
Mark Ruffalo – « Task » 2.5%
Gary Oldman – « Slow Horses » 2.3%
$20,351 Vol.
$20,351 Vol.
Noah Wyle – « The Pitt »
94%
Sterling K. Brown – « Paradise »
3%
Mark Ruffalo – « Task »
2%
Gary Oldman – « Slow Horses »
2%
Rufus Sewell – « The Diplomat »
2%
Noah Wyle – « The Pitt » 94%
Sterling K. Brown – « Paradise » 3.1%
Mark Ruffalo – « Task » 2.5%
Gary Oldman – « Slow Horses » 2.3%
$20,351 Vol.
$20,351 Vol.
Noah Wyle – « The Pitt »
94%
Sterling K. Brown – « Paradise »
3%
Mark Ruffalo – « Task »
2%
Gary Oldman – « Slow Horses »
2%
Rufus Sewell – « The Diplomat »
2%
This market will resolve according to the person who wins the 2026 Emmy award for “Outstanding lead actor in a drama series”.
If for any reason no winner is declared by October 31, 2026, 11:59 PM ET, or in case of overall cancellation or a tie for winner, this market will resolve in favor of the nominee which comes first in alphabetical order.
The primary resolution source for this market will be official information from the Academy of Television Arts & Sciences and the Emmys, including data from their websites (e.g. https://theemmys.tv/, https://www.televisionacademy.com/) and the live broadcast of the award ceremony, however a consensus of credible reporting may also be used.
Marché ouvert : Jul 9, 2026, 9:08 PM ET
Résolveur
0x69c47De9D...This market will resolve according to the person who wins the 2026 Emmy award for “Outstanding lead actor in a drama series”.
If for any reason no winner is declared by October 31, 2026, 11:59 PM ET, or in case of overall cancellation or a tie for winner, this market will resolve in favor of the nominee which comes first in alphabetical order.
The primary resolution source for this market will be official information from the Academy of Television Arts & Sciences and the Emmys, including data from their websites (e.g. https://theemmys.tv/, https://www.televisionacademy.com/) and the live broadcast of the award ceremony, however a consensus of credible reporting may also be used.
Résolveur
0x69c47De9D...Noah Wyle’s commanding lead in the Outstanding Lead Actor in a Drama Series market reflects The Pitt’s dominant 25-nomination haul and his status as defending champion, bolstered by strong critical reception for his layered portrayal of Dr. Robby in season two. Industry predictors and guild momentum have consolidated trader consensus around the HBO Max medical drama’s repeat frontrunner narrative, with Wyle’s episode submissions highlighting emotional depth that resonates with academy voters. The ceremony arrives September 14, leaving little room for late shifts, though a surge from established contenders like Gary Oldman or Sterling K. Brown could theoretically disrupt the outcome if voter fatigue or unexpected campaign dynamics emerge in final ballots.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes